haloperidol has been researched along with Morphine Abuse in 25 studies
Haloperidol: A phenyl-piperidinyl-butyrophenone that is used primarily to treat SCHIZOPHRENIA and other PSYCHOSES. It is also used in schizoaffective disorder, DELUSIONAL DISORDERS, ballism, and TOURETTE SYNDROME (a drug of choice) and occasionally as adjunctive therapy in INTELLECTUAL DISABILITY and the chorea of HUNTINGTON DISEASE. It is a potent antiemetic and is used in the treatment of intractable HICCUPS. (From AMA Drug Evaluations Annual, 1994, p279)
haloperidol : A compound composed of a central piperidine structure with hydroxy and p-chlorophenyl substituents at position 4 and an N-linked p-fluorobutyrophenone moiety.
| Excerpt | Relevance | Reference |
|---|---|---|
| "It was found that pimozide, haloperidol and alpha-methyl-p-tyrosine (alpha-MT), drugs inhibiting central catecholaminergic (CA) transmission, increased the development of morphine dependence measured as wet dog shakes in rats." | 7.66 | The influence of pimozide, haloperidol, alpha-methyl-p-tyrosine and reserpine on the development of morphine dependence in rats. ( Kruszewska, A; Langwiński, R, 1983) |
| "It was found that pimozide, haloperidol and alpha-methyl-p-tyrosine (alpha-MT), drugs inhibiting central catecholaminergic (CA) transmission, increased the development of morphine dependence measured as wet dog shakes in rats." | 3.66 | The influence of pimozide, haloperidol, alpha-methyl-p-tyrosine and reserpine on the development of morphine dependence in rats. ( Kruszewska, A; Langwiński, R, 1983) |
| "Pretreatment with haloperidol (0." | 1.37 | Haloperidol disrupts opioid-antinociceptive tolerance and physical dependence. ( Chen, Y; Tang, L; Wang, ZJ; Yang, C, 2011) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 20 (80.00) | 18.7374 |
| 1990's | 3 (12.00) | 18.2507 |
| 2000's | 1 (4.00) | 29.6817 |
| 2010's | 1 (4.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Yang, C | 1 |
| Chen, Y | 1 |
| Tang, L | 1 |
| Wang, ZJ | 1 |
| Kawasaki, Y | 1 |
| Jin, C | 1 |
| Suemaru, K | 1 |
| Kawasaki, H | 1 |
| Shibata, K | 1 |
| Choshi, T | 1 |
| Hibino, S | 1 |
| Gomita, Y | 1 |
| Araki, H | 1 |
| Kruszewska, A | 1 |
| Langwiński, R | 1 |
| Ferrari, F | 2 |
| Baggio, G | 1 |
| Samanin, R | 1 |
| Cervo, L | 1 |
| Rochat, C | 1 |
| Poggesi, E | 1 |
| Mennini, T | 1 |
| Fukase, H | 1 |
| Fukuzaki, K | 1 |
| Koja, T | 1 |
| Nagata, R | 1 |
| Lukas, SE | 1 |
| Borg, PJ | 1 |
| Taylor, DA | 1 |
| Ballard, TM | 1 |
| McAllister, KH | 1 |
| Hine, B | 2 |
| Gershon, S | 2 |
| Baldino, F | 1 |
| Cowan, A | 1 |
| Geller, EB | 1 |
| Adler, MW | 1 |
| Zaluzny, SG | 1 |
| Chesher, GB | 1 |
| Jackson, DM | 1 |
| Malor, R | 1 |
| Maltbie, AA | 1 |
| Cavenar, JO | 1 |
| Sullivan, JL | 1 |
| Hammett, EB | 1 |
| Eidelberg, E | 1 |
| Erspamer, R | 1 |
| Iwamoto, ET | 1 |
| Way, EL | 1 |
| Drawbaugh, RB | 1 |
| Lal, H | 3 |
| Tseng, LF | 1 |
| Brase, DA | 1 |
| Loh, HH | 1 |
| Friedman, E | 1 |
| Torrelio, M | 1 |
| Van der Laan, JW | 1 |
| Tampieri, A | 1 |
| Mangiafico, V | 1 |
| Holtzman, SG | 1 |
| Cicero, TJ | 1 |
| Meyer, ER | 1 |
| Bell, RD | 1 |
| Schwartz, AS | 1 |
| Marchok, PL | 1 |
| Puri, SK | 1 |
| Puri, S | 1 |
| Martin, WR | 1 |
| Eades, CG | 1 |
| Thompson, WO | 1 |
| Thompson, JA | 1 |
| Flanary, HG | 1 |
| Trial | Phase | Enrollment | Study Type | Start Date | Status | ||
|---|---|---|---|---|---|---|---|
| Conditioning & Open-Label Placebo (COLP) for Opioid Management in Intensive Inpatient Rehabilitation[NCT05351333] | 66 participants (Anticipated) | Interventional | 2022-08-03 | Recruiting | |||
| [information is prepared from clinicaltrials.gov, extracted Sep-2024] | |||||||
25 other studies available for haloperidol and Morphine Abuse
| Article | Year |
|---|---|
Haloperidol disrupts opioid-antinociceptive tolerance and physical dependence.
Topics: Analgesics, Opioid; Animals; Calcium-Calmodulin-Dependent Protein Kinase Type 2; Dose-Response Relat | 2011 |
Effect of glutamate receptor antagonists on place aversion induced by naloxone in single-dose morphine-treated rats.
Topics: Animals; Avoidance Learning; Conditioning, Psychological; Dopamine Antagonists; Excitatory Amino Aci | 2005 |
The influence of pimozide, haloperidol, alpha-methyl-p-tyrosine and reserpine on the development of morphine dependence in rats.
Topics: 5-Hydroxytryptophan; alpha-Methyltyrosine; Animals; Catecholamines; Haloperidol; Humans; Male; Methy | 1983 |
Influence of lisuride on morphine withdrawal signs in the rat: a dopamine-mimetic effect.
Topics: Aggression; Animals; Apomorphine; Dopamine; Ergolines; Haloperidol; Humans; Lisuride; Male; Morphine | 1982 |
Reduction in the number of serotonin receptors in the brainstem of morphine dependent rats: relation to blockade of naloxone precipitated jumping by serotonin agonists.
Topics: Animals; Behavior, Animal; Brain Stem; Clonidine; Haloperidol; Humans; Male; Morphine Dependence; Na | 1980 |
Effects of morphine, naloxone, buprenorphine, butorphanol, haloperidol and imipramine on morphine withdrawal signs in cynomolgus monkeys.
Topics: Animals; Behavior, Animal; Buprenorphine; Butorphanol; Haloperidol; Imipramine; Macaca fascicularis; | 1994 |
Voluntary oral morphine self-administration in rats: effect of haloperidol or ondansetron.
Topics: Animals; Behavior, Animal; Defecation; Haloperidol; Injections, Intramuscular; Male; Morphine; Morph | 1994 |
Acutely administered clozapine does not modify naloxone-induced withdrawal jumping in morphine-dependent mice.
Topics: Analgesics; Animals; Antipsychotic Agents; Clonidine; Clozapine; Haloperidol; Male; Mice; Morphine D | 1999 |
Haloperidol attenuation of morphine abstinence: synergistic effect of acute lithium administration.
Topics: Animals; Drug Synergism; Haloperidol; Humans; Lithium; Male; Methyltyrosines; Morphine Dependence; N | 1977 |
Effects of antipsychotic and antianxiety drugs on the morphine abstinence syndrome in rats.
Topics: Animals; Anti-Anxiety Agents; Antipsychotic Agents; Behavior, Animal; Body Weight; Chlordiazepoxide; | 1979 |
The attenuation of delta 9-tetrahydrocannabinol and morphine of the quasi-morphine withdrawal syndrome in rats.
Topics: 1-Methyl-3-isobutylxanthine; Animals; Behavior, Animal; Chlordiazepoxide; Dronabinol; Haloperidol; H | 1979 |
Haloperidol treatment of a sixty-year narcotic addiction: case report.
Topics: Aged; Haloperidol; Humans; Male; Morphine Dependence; Time Factors | 1979 |
Dopaminergic mechanisms of opiate actions in brain.
Topics: Analgesics; Animals; Brain; Dopamine; Drug Synergism; Drug Tolerance; Haloperidol; Humans; Levodopa; | 1975 |
Circling behavior and stereotypy induced by intranigral opiate microinjections.
Topics: Analgesia; Animals; Behavior; Endorphins; Haloperidol; Humans; Hydroxydopamines; Injections; Male; M | 1977 |
Effect of pharmacological interference with various neuropathways on blockade of morphine-withdrawal hypothermia by morphine and by conditional stimulus.
Topics: Animals; Benztropine; Conditioning, Classical; Cyproheptadine; Haloperidol; Humans; Hypothermia; Mal | 1976 |
Dopaminergic influence on withdrawal jumping behavior in morphine-dependent mice.
Topics: Animals; Apomorphine; Brain; Dopamine; Dose-Response Relationship, Drug; Haloperidol; Humans; Male; | 1976 |
Tetrahydrocannabinol-attenuated abstinence and induced rotation in morphine-dependent rats: possible involvement of dopamine.
Topics: Animals; Behavior; Cannabis; Dopamine; Dronabinol; Haloperidol; Humans; Male; Morphine Dependence; N | 1975 |
Dopaminergic and alpha 1-adrenergic properties of B-HT920 revealed in morphine-dependent rats.
Topics: Adrenergic alpha-Agonists; Animals; Azepines; Dopamine; Haloperidol; Lisuride; Male; Morphine Depend | 1987 |
Imidazole modification of aggressive behaviour in rats and mice.
Topics: Aggression; Animals; Haloperidol; Imidazoles; Lisuride; Male; Mice; Morphine Dependence; Rats; Rats, | 1987 |
Discriminative stimulus effects of morphine withdrawal in the dependent rat: suppression by opiate and nonopiate drugs.
Topics: Animals; Body Weight; Clonidine; Haloperidol; Humans; Male; Morphine Dependence; Naloxone; Naltrexon | 1985 |
Effects of phenoxybenzamine on the narcotic withdrawal syndrome in the rat.
Topics: Adrenergic beta-Antagonists; Animals; Behavior, Animal; Body Weight; Chlorpromazine; Depression, Che | 1974 |
Depression of morphine-seeking behaviour by dopamine inhibition.
Topics: Animals; Chelating Agents; Conditioning, Operant; Dopamine Antagonists; Dopamine beta-Hydroxylase; F | 1974 |
Tolerance to the behavioral and neurochemical effects of haloperidol and morphine in rats chronically treated with morphine or haloperidol.
Topics: Animals; Behavior, Animal; Catalepsy; Corpus Striatum; Dopamine; Drug Tolerance; Haloperidol; Humans | 1974 |
Effect of dopaminergic stimulation or blockade on morphine-withdrawal aggression.
Topics: Aggression; Amphetamine; Animals; Apomorphine; Dihydroxyphenylalanine; Haloperidol; Humans; Male; Me | 1973 |
Morphine physical dependence in the dog.
Topics: Animals; Behavior, Animal; Body Temperature; Body Weight; Dogs; Dose-Response Relationship, Drug; Ha | 1974 |